In:
PeerJ, PeerJ, Vol. 10 ( 2022-01-24), p. e12819-
Abstract:
Aspirin is a common antipyretic, analgesic, and anti-inflammatory drug, which has been reported to extend life in animal models and application in the treatment of aging-related diseases. However, it remains unclear about the effects of aspirin on bone marrow-derived mesenchymal stromal cells (BM-MSCs). Here, we aimed to analyze the influence of aspirin on senescence and young BM-MSCs. Methods BM-MSCs were serially passaged to construct a replicative senescence model. SA-β-gal staining, PCR, western blot, and RNA-sequencing were performed on BM-MSCs with or without aspirin treatment, to examine aspirin’s impact on bone marrow-derived mesenchymal stem cells. Results SA-β-gal staining, PCR, and western blot revealed that aspirin could alleviate the cellular expression of senescence-related indicators of BM-MSCs, including a decrease of SA-β-gal-positive cells and staining intensity, and downregulation of p16, p21, and p53 expression after aspirin treatment. RNA-sequencing results shown in the biological processes related to aging, aspirin could influence cellular immune response and lipid metabolism. Conclusion The efficacy of aspirin for retarding senescence of BM-MSCs was demonstrated. Our study indicated that the mechanisms of this delay might involve influencing immune response and lipid metabolism.
Type of Medium:
Online Resource
ISSN:
2167-8359
DOI:
10.7717/peerj.12819/fig-1
DOI:
10.7717/peerj.12819/fig-2
DOI:
10.7717/peerj.12819/fig-3
DOI:
10.7717/peerj.12819/fig-4
DOI:
10.7717/peerj.12819/fig-5
DOI:
10.7717/peerj.12819/fig-6
DOI:
10.7717/peerj.12819/fig-7
DOI:
10.7717/peerj.12819/table-1
DOI:
10.7717/peerj.12819/supp-1
DOI:
10.7717/peerj.12819/supp-2
DOI:
10.7717/peerj.12819/supp-3
DOI:
10.7717/peerj.12819/supp-4
DOI:
10.7717/peerj.12819/supp-5
DOI:
10.7717/peerj.12819/supp-6
DOI:
10.7717/peerj.12819/supp-7
DOI:
10.7717/peerj.12819/supp-8
DOI:
10.7717/peerj.12819/supp-9
DOI:
10.7717/peerj.12819/supp-10
DOI:
10.7717/peerj.12819/supp-11
DOI:
10.7717/peerj.12819/supp-12
DOI:
10.7717/peerj.12819/supp-13
DOI:
10.7717/peerj.12819/supp-14
DOI:
10.7717/peerj.12819/supp-15
DOI:
10.7717/peerj.12819/supp-16
DOI:
10.7717/peerj.12819/supp-17
DOI:
10.7717/peerj.12819/supp-18
DOI:
10.7717/peerj.12819/supp-19
DOI:
10.7717/peerj.12819/supp-20
DOI:
10.7717/peerj.12819/supp-21
DOI:
10.7717/peerj.12819/supp-22
DOI:
10.7717/peerj.12819/supp-23
DOI:
10.7717/peerj.12819/supp-24
Language:
English
Publisher:
PeerJ
Publication Date:
2022
detail.hit.zdb_id:
2703241-3
Bookmarklink